HPS Pharmacies wish to advise that AbbVie is discontinuing all Chirocaine® (levobupivacaine) products in Australia, as follows:
|Product||ARTG||Approximate discontinuation date|
|Chriocaine® 50mg/10ml ampoule||76862||December 2022|
|Chriocaine® 25mg/10ml ampoule||76815||December 2022|
|Chriocaine® 75mg/10ml ampoule||76864||September 2023|
|Chriocaine® 250mg/200ml bag||94482||June 2023|
No alternative brands of levobupivacaine are currently marketed in Australia.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact AbbVie on 1800 043 460, or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates